Capricorn Venture Partners

Minze Health is a Belgian healthech startup that develops digital health solutions for the treatment of urinary tract problems. The company's digital health and remote patient monitoring (RPM) solutions are being used by hospitals, urology practices, and pelvic floor rehabilitation centers worldwide. Minze Health was established in 2015 and is headquartered in Antwerp, Belgium.

Chainels is a comprehensive tenant experience platform designed for multi-tenant environments such as shopping centers, mixed-use developments, offices, and residential complexes. Based in Rotterdam, the company aims to enhance communication and tenant retention by providing an intuitive app that facilitates the management of operations, amenities, and data reporting. The platform enables stakeholders to streamline property management processes and deliver high-quality services to tenants. Chainels serves over 400 communities, encompassing around 50,000 companies and households across multiple countries. Its client base includes notable organizations like Multi Corporation, Amvest/Fuzer, and CBRE, highlighting its impact on improving tenant experiences and operational efficiency in various property types.

Minze Health is a Belgian healthech startup that develops digital health solutions for the treatment of urinary tract problems. The company's digital health and remote patient monitoring (RPM) solutions are being used by hospitals, urology practices, and pelvic floor rehabilitation centers worldwide. Minze Health was established in 2015 and is headquartered in Antwerp, Belgium.

Gradyent is an AI cloud platform based in Utrecht, The Netherlands, that specializes in optimizing heating systems for district heating companies. Founded in 2019, Gradyent leverages Digital Twin technology, which involves creating a digital replica of physical heating systems by integrating geographical, weather, and sensor data with physical models and artificial intelligence. This innovative approach allows for real-time optimization of heating systems and facilitates simulations of future scenarios. As a result, clients can achieve significant reductions in heat loss, CO2 emissions, and fuel costs—averaging 20%, 10%, and 5-10%, respectively. Gradyent's platform not only enhances the efficiency of heating networks but also provides dynamic forecasting, real-time status updates, and automatic detection of network changes, allowing clients to securely access vital information from any location at any time.

Finquest is a leading deal origination provider that specializes in delivering personalized connections for clients seeking mergers and acquisitions (M&A) and direct investment opportunities across Europe, North America, and the Asia-Pacific region. Utilizing a unique database and advanced machine learning techniques, Finquest offers targeted and curated introductions, facilitating a more efficient deal-making process while ensuring complete confidentiality. The company's platform focuses on the middle market, connecting institutional investors with potential investment opportunities and enabling corporate buyers to identify relevant acquirers. Headquartered in Singapore, Finquest operates offices in key financial centers including New York, Dallas, London, Paris, Frankfurt, Luxembourg, Bangalore, and Hong Kong, broadening market access for its clients.

Sensolus NV specializes in the design and development of GPS trackers for non-powered assets, providing comprehensive tracking solutions directly from the cloud. Established in 2013 and based in Ghent, Belgium, the company offers a range of low-power, context-aware sensing technologies, including its STICKNTRACK product line. Sensolus combines hardware GPS trackers with a fully integrated cloud application, enabling users to manage and monitor their assets with ease. The company serves various industries, including manufacturing, waste management, cargo transport, logistics, and automotive, focusing on delivering real-time information and maintenance-free asset tracking solutions.

Gradyent is an AI cloud platform based in Utrecht, The Netherlands, that specializes in optimizing heating systems for district heating companies. Founded in 2019, Gradyent leverages Digital Twin technology, which involves creating a digital replica of physical heating systems by integrating geographical, weather, and sensor data with physical models and artificial intelligence. This innovative approach allows for real-time optimization of heating systems and facilitates simulations of future scenarios. As a result, clients can achieve significant reductions in heat loss, CO2 emissions, and fuel costs—averaging 20%, 10%, and 5-10%, respectively. Gradyent's platform not only enhances the efficiency of heating networks but also provides dynamic forecasting, real-time status updates, and automatic detection of network changes, allowing clients to securely access vital information from any location at any time.

iSTAR Medical SA was created in 2010 as a spinout of Healionics Corporation with support from Belgium's Region Wallonne government. In 2011, iSTAR expanded to its new eco-friendly R&D and Manufacturing facility in CREALYS Scientific Park near Namur, Belgium. By 2012, iSTAR received ISO 13485 and ISO 9001 Quality Systems Certifications and achieved CE Mark approval of its first device - STARflo™ Glaucoma Implant.

Arkite NV, founded in 2015 and based in Genk, Belgium, specializes in manufacturing automation products designed to enhance operational efficiency in manufacturing environments. Their flagship product, the Human Interface Mate (HIM), aids operators by providing real-time warnings for incorrect operations and guiding them towards standardized work processes. The company emphasizes the importance of a dedicated team with expertise in industrial engineering, lean thinking, and process innovation. In addition to their product offerings, Arkite provides professional services, including process innovation consultancy, integration services, training, and support during the startup phase. They also assist clients with time studies for technology innovation, knowledge management to improve quality systems, and organizational innovations aimed at reducing throughput times.

icometrix is a company that specializes in the analysis of brain MRI scans to enhance personalized care for patients with neurological disorders. Founded in 2011 as a spin-off from the universities and university hospitals of Leuven and Antwerp, icometrix is headquartered in Leuven, Belgium, with an additional office in Boston, USA. The company has developed MSmetrix, a tool that identifies brain lesions, measures lesion volume, and assesses whole brain and grey matter volume and atrophy. MSmetrix has received market approval in the EU and several other countries, with FDA clearance pending. icometrix is recognized as a leader in MRI biomarkers for routine clinical practice and is certified in quality management and information security. Additionally, the company provides image analysis services for clinical trials and research studies, utilizing its software-as-a-service model to process large volumes of brain imaging data. This approach aids in advancing research on various neurological conditions, including traumatic brain injury, epilepsy, Alzheimer’s disease, and stroke, by using imaging biomarker outcomes as key endpoints in drug development.

Confo Therapeutics is a drug discovery company based in Brussels, Belgium, founded in 2015. The company focuses on developing internal drug discovery programs centered on G-protein coupled receptors (GPCRs), which are critical targets for therapeutic intervention. Utilizing its proprietary CONFO technology, Confo Therapeutics stabilizes active-state conformations of GPCRs, enabling researchers to access previously unreachable structural features. This innovation facilitates the discovery of novel agonists, addressing unmet medical needs and potentially leading to improved treatments in the medical field. The company aims to build a robust portfolio of drug discovery programs, leveraging its unique approach to enhance therapeutic options.

NGDATA is a company specializing in data management systems that focus on enhancing customer experience and lifetime value for enterprises. It offers a customer data platform named Lily, which integrates big data management and machine learning technologies to provide real-time insights from diverse data sources. This platform allows businesses to gain a comprehensive view of customer interactions, enabling them to engage more effectively and drive customer loyalty. NGDATA serves various industries, including retail, e-commerce, finance, media, and telecommunications. Headquartered in Ghent, Belgium, the company also has offices in Singapore, Paris, New York City, and San Francisco.

Arkite NV, founded in 2015 and based in Genk, Belgium, specializes in manufacturing automation products designed to enhance operational efficiency in manufacturing environments. Their flagship product, the Human Interface Mate (HIM), aids operators by providing real-time warnings for incorrect operations and guiding them towards standardized work processes. The company emphasizes the importance of a dedicated team with expertise in industrial engineering, lean thinking, and process innovation. In addition to their product offerings, Arkite provides professional services, including process innovation consultancy, integration services, training, and support during the startup phase. They also assist clients with time studies for technology innovation, knowledge management to improve quality systems, and organizational innovations aimed at reducing throughput times.

Sensolus NV specializes in the design and development of GPS trackers for non-powered assets, providing comprehensive tracking solutions directly from the cloud. Established in 2013 and based in Ghent, Belgium, the company offers a range of low-power, context-aware sensing technologies, including its STICKNTRACK product line. Sensolus combines hardware GPS trackers with a fully integrated cloud application, enabling users to manage and monitor their assets with ease. The company serves various industries, including manufacturing, waste management, cargo transport, logistics, and automotive, focusing on delivering real-time information and maintenance-free asset tracking solutions.

NGDATA is a company specializing in data management systems that focus on enhancing customer experience and lifetime value for enterprises. It offers a customer data platform named Lily, which integrates big data management and machine learning technologies to provide real-time insights from diverse data sources. This platform allows businesses to gain a comprehensive view of customer interactions, enabling them to engage more effectively and drive customer loyalty. NGDATA serves various industries, including retail, e-commerce, finance, media, and telecommunications. Headquartered in Ghent, Belgium, the company also has offices in Singapore, Paris, New York City, and San Francisco.

Diagenode is an international life sciences company that develops and commercializes innovative instruments and reagents systems for life science research and molecular diagnostics. Founded in 2003 in Liege (Belgium), Diagenode is a global company, with headquarters in Liege, Belgium and Sparta, NJ, USA. Diagenode also has a local sales office in the United Kingdom to better serve this specific country. Diagenode's customers include leading epigenetics researchers, academic institutions, high-profile genome centers and core labs, life sciences tools companies, molecular diagnostics players, and pharmaceutical and biotechnology companies. Epigenetics Division

iSTAR Medical SA was created in 2010 as a spinout of Healionics Corporation with support from Belgium's Region Wallonne government. In 2011, iSTAR expanded to its new eco-friendly R&D and Manufacturing facility in CREALYS Scientific Park near Namur, Belgium. By 2012, iSTAR received ISO 13485 and ISO 9001 Quality Systems Certifications and achieved CE Mark approval of its first device - STARflo™ Glaucoma Implant.

NGDATA is a company specializing in data management systems that focus on enhancing customer experience and lifetime value for enterprises. It offers a customer data platform named Lily, which integrates big data management and machine learning technologies to provide real-time insights from diverse data sources. This platform allows businesses to gain a comprehensive view of customer interactions, enabling them to engage more effectively and drive customer loyalty. NGDATA serves various industries, including retail, e-commerce, finance, media, and telecommunications. Headquartered in Ghent, Belgium, the company also has offices in Singapore, Paris, New York City, and San Francisco.

Ogeda SA is a clinical-stage drug discovery company based in Gosselies, Belgium, that focuses on inventing and developing small molecule drugs that target G-Protein Coupled Receptors (GPCRs). The company's lead product, fezolinetant, is currently in Phase II clinical development for treating women's health disorders. In addition to fezolinetant, Ogeda is developing other small molecules aimed at addressing various therapeutic areas, including inflammatory and autoimmune diseases. Founded in 1994 and formerly known as Euroscreen, Ogeda operates additional facilities in Brussels, Belgium, and Paris, France. The company is a subsidiary of Astellas Pharma Inc. and is supported by prominent investors in the biotechnology sector.

Avantium is a leading technology company specialized in advanced high-throughput R&D for applications in the energy, chemicals and pharmaceutical industries. The company's headquarters and laboratories are located in Amsterdam, in the Netherlands. Avantium's proprietary high-throughput technology enables a faster and more cost-effective development of new and improved products and production processes. Using its unique rational approach towards the design of experiments and data analysis, Avantium is capable of accomplishing innovations with superior success rate. Avantium has demonstrated the validity and commercial viability of its technology by successfully providing research services and tools to more than 70 companies worldwide, including many industry leaders. The company's mission is to increase the success rate and economics of product and process development. Building on its expertise and track record in the energy, chemicals and pharmaceutical industries, Avantium focuses on developing products in two fields: new biofuels and bio-based chemicals, and new crystal forms of marketed drugs under patent. Avantium's strategy is to progress its development programs and exploit the commercial value of its expanding patent portfolio by securing value-adding partnerships during the coming years. Avantium seeks continuous expansion of its profitable services and tools business. Avantium has assembled a team of highly educated professionals who are experts in catalysis, crystallography, organic chemistry, engineering of robotic systems, process engineering, statistics, cheminformatics and software development. Its teams collaborate closely with partner R&D organizations.

iSTAR Medical SA was created in 2010 as a spinout of Healionics Corporation with support from Belgium's Region Wallonne government. In 2011, iSTAR expanded to its new eco-friendly R&D and Manufacturing facility in CREALYS Scientific Park near Namur, Belgium. By 2012, iSTAR received ISO 13485 and ISO 9001 Quality Systems Certifications and achieved CE Mark approval of its first device - STARflo™ Glaucoma Implant.

Trod Medical S.A. is a medical device manufacturer founded in 2006, with headquarters in Leuven, Belgium, and the Tampa Bay area, USA. The company specializes in innovative ablation technologies, particularly in developing radiofrequency (RF) ablation devices. One of its key products, the EncageTM, is a percutaneous RF device designed to precisely ablate soft tissues, minimizing collateral damage during procedures. This technology is particularly significant in the treatment of prostate cancer, a prevalent condition with approximately 240,000 new cases diagnosed annually in the United States. Traditional treatments often lead to severe side effects, such as erectile dysfunction and urinary incontinence, highlighting the importance of Trod Medical's advancements. The company's devices enable healthcare providers to perform endoscopic surgeries with predictable ablation volumes and reduced tissue damage, aiming to improve patient outcomes in a critical area of medical care.

NGDATA is a company specializing in data management systems that focus on enhancing customer experience and lifetime value for enterprises. It offers a customer data platform named Lily, which integrates big data management and machine learning technologies to provide real-time insights from diverse data sources. This platform allows businesses to gain a comprehensive view of customer interactions, enabling them to engage more effectively and drive customer loyalty. NGDATA serves various industries, including retail, e-commerce, finance, media, and telecommunications. Headquartered in Ghent, Belgium, the company also has offices in Singapore, Paris, New York City, and San Francisco.

Trinean is a Belgium-based technology provider that specializes in micro-volume molecular spectroscopy. Founded in 2006 as a spin-out from Ghent University and Imec Leuven, the company develops UV/VIS spectrometers tailored for biomolecule quantification. Its products, the DropSense™16 and DropSense™96, can analyze up to 16 and 96 samples, respectively, utilizing microfluidic chips for standardized sample analysis. These instruments are designed to enhance data interpretation and facilitate laboratory automation, making them valuable tools for biologics researchers. Trinean combines its advanced analytical hardware with a comprehensive software toolbox to optimize the performance of its spectrometers.

EpiGaN, a Leuven, Belgium-based company that develops Gallium Nitride on Silicon (GaN) on-silicon wafers...

Ducatt NV is a clean-tech start-up located in Belgium that specializes in the manufacturing of solar glasses. These ultra-clear patterned glasses are designed to enhance the efficiency of solar systems, offering various thicknesses to meet different client needs. Ducatt's products aim to make solar technology more accessible and affordable, contributing to the growing demand for sustainable energy solutions.

Anteryon, based in Eindhoven, the Netherlands, is a manufacturer specializing in optical precision elements and miniature optical modules. Originally a business unit of Philips, it became an independent entity in 2006. The company focuses on providing standard and customized optical components, utilizing patented replication and opto-mechanical assembly technologies, alongside expertise in coatings, lithography, and precision glass. Anteryon serves diverse markets, including industrial, imaging and display, and data and telecom, delivering solutions that encompass lenses, laser modules, fiber collimators, and integrated lens stacks. Its products are integral to various applications, such as automotive safety systems, optical data storage, and multiview displays. Notably, Anteryon's innovations include WaferOptics® technology, facilitating advanced stacking techniques at the wafer level. The company is well-positioned for growth in the mobile phone camera module sector, catering to an expanding global demand for camera-enabled devices.

Avantium is a leading technology company specialized in advanced high-throughput R&D for applications in the energy, chemicals and pharmaceutical industries. The company's headquarters and laboratories are located in Amsterdam, in the Netherlands. Avantium's proprietary high-throughput technology enables a faster and more cost-effective development of new and improved products and production processes. Using its unique rational approach towards the design of experiments and data analysis, Avantium is capable of accomplishing innovations with superior success rate. Avantium has demonstrated the validity and commercial viability of its technology by successfully providing research services and tools to more than 70 companies worldwide, including many industry leaders. The company's mission is to increase the success rate and economics of product and process development. Building on its expertise and track record in the energy, chemicals and pharmaceutical industries, Avantium focuses on developing products in two fields: new biofuels and bio-based chemicals, and new crystal forms of marketed drugs under patent. Avantium's strategy is to progress its development programs and exploit the commercial value of its expanding patent portfolio by securing value-adding partnerships during the coming years. Avantium seeks continuous expansion of its profitable services and tools business. Avantium has assembled a team of highly educated professionals who are experts in catalysis, crystallography, organic chemistry, engineering of robotic systems, process engineering, statistics, cheminformatics and software development. Its teams collaborate closely with partner R&D organizations.

iNEWiT, an engineering company, engages in identifying, designing, and creating applications and devices for the mobile market. It provides mobile video communication applications; wireless communication technologies, ranging from GPRS/EDGE, over 3G, HSDPA/HSUPA to WiFi, and WiMAX and satellite networks; and plug and play products for the business-to-consumer markets. The company was founded in 2005 and is based in Mechelen, Belgium

Gemidis is a spin-off company from Ghent University (Belgium) and IMEC (Belgium) and was officially founded in August 2004. Gemidis develops, produces and sells LCOS imagers and driver electronics for both consumer and professional markets.

TiGenix NV is a Belgium-based biomedical company specializing in innovative treatments for damaged and osteoarthritic joints. Founded as a spin-off from the Catholic University of Leuven and the University of Ghent, TiGenix leverages regenerative medicine to create durable therapies validated through controlled clinical studies. The company focuses on developing a portfolio of products aimed at addressing specific musculoskeletal issues, with a primary emphasis on cartilage damage, which significantly impairs patient mobility and function. TiGenix also explores the anti-inflammatory properties of stem cells to create novel therapies for serious medical conditions, particularly in areas where there is a high unmet medical need.